Madhurima Kahali, marketing team head at Taylor & Francis Group, talks about her experience transitioning from academia to the publishing industry. In this '10 Women, 10 Questions' interview, Kahali discusses her career trajectory, starting from being an editor at a leading global publisher to becoming the head of a marketing team.
Posted on in Other, Science Communication, Women in Science, Career Development & Ethics
As artificial intelligence (AI) enables the transformation of biology into an engineering discipline, an effective governance model that uses threat forecasting, real-time evaluation, and response strategies is urgently needed to address accidental or deliberate misuse. This article talks about the risks at the interface of AI and biosecurity and what could India do to better prepare for potential AI-biorisks.
Sabuj Bhattacharyya is the Research Ethics and Integrity Officer at the Biotechnology Research and Innovation Council-Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), Bengaluru. In this interview, he speaks to Bharti Dharapuram, an ecologist and science writer, about the multiple facets of research ethics, the joys and challenges of teaching it, and building a more mindful research culture.
Open science, particularly through preprints, is gaining global traction and is integral to India's Science, Technology, and Innovation Policy. While preprints offer accessibility benefits, their adoption in India lags, highlighting the need for recognition and incentives at various career and funding assessment levels. In this article, Sudeepa Nandi, an ASAPbio fellow and a PhD student at TIFR Mumbai, discusses the barriers to the preprint model in India and offers some key recommendations.
The Anusandhan National Research Foundation (NRF) Bill 2023 in India aims to enhance research funding in universities and colleges, yet concerns persist regarding its autonomy and operational effectiveness. In this article from our current conversation series, Joel P. Joseph discusses the 'what' and 'how' of the NRF bill.
Artificial Intelligence is revolutionising various aspects of life sciences, from drug discovery and disease diagnosis to education, showing great promise in improving healthcare and enhancing learning. But, caution is needed in its application, considering challenges like lack of generalisation across patient populations and the risk of over-reliance, as human collaboration and thoughtful use remain essential for its successful integration..
Suryesh K Namdeo, DST- Centre for Policy Research (DST-CPR), IISc, Bengaluru, highlights the growing biological risks in the modern era, fuelled by advancements in areas such as synthetic biology, neurotechnology, and artificial intelligence. While these technologies offer promising applications in various fields, they also raise concerns about the potential misuse and accidental release of harmful biological agents.